Atomera Q3 net loss improves to $4.6M; collaboration with Sandia on GaN

Atomera Inc

2024-Q3 EPS reported -$0.52 revenue$112,000

Net loss of $4.6M ($0.17 per share) compared to $5.0M loss ($0.20 per share) in Q3 2023.
Adjusted EBITDA loss narrowed to $3.9M from $4.3M year-over-year.
Cash and short-term investments fell to $17.3M from $19.5M at year-end 2023.
Revenue of $22K in Q3 2024, down from $72K in Q2 2024.
Announced collaboration with Sandia National Labs to validate MST for GaN manufacturing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.